Professor, Internal Medicine, University of Iowa Roy J. and Lucille A. Carver CO
Hematology
Dr. Guido Tricot, MD
|
|
Give Review
Guido Tricot, MD works in the field of Hematology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Guido Tricot is a published doctor. He published 17 publications, including: 'Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus.' He is registered with Medicare and accepts Medicare payments.
Publications
- Junctional adhesion molecule-A is overexpressed in advanced multiple Myeloma and determines response to oncolytic reovirus.
- Adoptive B-cell transfer mouse model of human Myeloma.
- Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple Myeloma.
- A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple Myeloma.
- Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple Myeloma undergoing a second autologous blood...
- NEK2 mediates ALDH1A1 induced drug-resistance in multiple Myeloma.
- Preclinical validation of interleukin 6 as a therapeutic target in multiple Myeloma.
- Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for ...
- ALDH1 Activity identifies tumor initiating cells and links to chromosomal instability signatures in multiple Myeloma.
- Parathyroid hormone receptor mediates the anti-Myeloma effect of proteasome inhibitors.
- RARα2 expression confers Myeloma stem cell features.
- NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers.
- Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in Myeloma patients with metaphase cytogenetic abnormalities.
- Nek2 is a novel regulator of B cell development and immunological response.
- Inhibition of nek2 by small molecules affects proteasome activity.
- (18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple Myeloma affords objective evaluation of plasma cell tumor progression and therapeutic...
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Catholic University of Leuven Faculty of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Steven R. Lentz, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ahmad M. Wehbe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles P. Burns, MD |
|
|
Dr. Thorvardur R. Halfdanarson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lori J. Rosenstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George J. Weiner, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jose P. Leone, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark W. Karwal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grerk Sutamewagul, MD |